| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
MacIas William L. is a Chief Medical Officer at Immunovant, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $10.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 2,055 | $20.86 | $42,867.30 | -0.6% | -28.0% | +26.6% | |
| Jan 15, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 2,383 | $23.83 | $56,782.17 | -0.2% | -36.6% | +6.6% | |
| Nov 20, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 3,353 | $25.45 | $85,333.85 | -0.9% | -20.4% | -12.9% | |
| Oct 16, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 3,188 | $28.79 | $91,782.52 | -0.4% | -21.6% | -40.3% | |
| Aug 21, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 3,027 | $31.86 | $96,437.28 | -0.4% | -22.3% | -54.3% | |
| Jul 17, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 3,044 | $29.69 | $90,386.14 | -0.2% | -4.8% | -39.0% | |
| May 22, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 3,247 | $29.65 | $96,273.55 | -0.9% | +6.6% | -50.7% | |
| Apr 17, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 8,280 | $29.06 | $240,601.50 | -0.5% | +8.8% | -46.7% | |
| Feb 22, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 2,221 | $36.15 | $80,289.15 | -0.7% | -17.9% | -40.9% | |
| Jan 18, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 424 | $41.03 | $17,396.72 | -0.1% | -29.9% | -41.1% |